Filing Details

Accession Number:
0001576427-16-000241
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-17 16:15:13
Reporting Period:
2016-05-17
Filing Date:
2016-05-17
Accepted Time:
2016-05-17 16:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576427 Criteo S.a. CRTO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204818 L Dana Evan C/O Criteo Legal Dept.
387 Park Avenue South, 11Th Floor
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-05-17 10,000 $10.90 10,000 No 4 M Direct
Ordinary Shares Disposition 2016-05-17 10,000 $44.60 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-employee Warrant (right to buy) Disposition 2016-05-17 10,000 $0.00 10,000 $10.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,600 2015-03-06 2023-03-06 No 4 M Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.90 using the Federal Reserve Bank of New York noon buying rate for May 13, 2016 (1.00 = $1.1294)
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $44.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.